Shanghai First Song Biotechnology Co., LTD
2 clinical trials · Sponsor
◉ Watch Shanghai First Song Biotechnology Co., LTD
| Record | Firm | Date |
|---|---|---|
| Anti-CD19-CAR-T Cells in Subjects With Relapsed/Refractory B Cell Malignancies (NCT06532630) | Shanghai First Song Biotechnology Co., LTD | 2023-08-24 |
Track Shanghai First Song Biotechnology Co., LTD automatically
Every clearance here is in the API, with alerts when new ones post.